Page values for "Terbinafine"
Appearance
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Terbinafine |
| brand | String | Lamisil; OTC topical Lamisil AT |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antifungals|Antifungal (allylamine)]] • [[:Category:Allylamines|Allylamine]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000EAF-QINU`"', '"`UNIQ--vote-00000EB0-QINU`"', '"`UNIQ--vote-00000EB1-QINU`"' |
| starting_dose | String | Oral: 250 mg PO once daily × 6 weeks (fingernails) or 12 weeks (toenails); topical: cream BID × 1-2 weeks |
| preparations | String | 250 mg tablets; 1% topical cream, gel, spray; granules (pediatric) |
| fda_max | String | 250 mg/d |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • topical |
| onset | String | Clinical and mycologic cure follows the full course; nail clearance over months of regrowth |
| duration | String | 24 hours |
| halflife | String | ~36 hours (terminal much longer due to tissue accumulation in skin/nails)'"`UNIQ--ref-00000EB2-QINU`"' |
| bioavailability | String | ~40% (oral; food does not significantly affect)'"`UNIQ--ref-00000EB3-QINU`"' |
| pregnancy | String | Limited data; generally avoided in pregnancy for the cosmetic indication of onychomycosis.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | OTC (topical) and [[USLegal:Prescription only|Rx-only]] (oral) in US |